2012-04-01
PL-17 risk and management of thrombosis in multiple myeloma
Publication
Publication
Thrombosis Research: vascular obstruction, hemorrhage and hemostasis , Volume 129 - Issue SUPPL. 1
Patients diagnosed with multiple myeloma have an increased risk of venous thrombosis. This may be due to various risk factors, including disease specific factors, changes in coagulation and fibrinolysis factors and circulating prothrombotic microparticles. More recent studies have indicated that also arterial thrombosis, including acute myocardial infarction and stroke do occur more frequently in these patients. Studies on etiological factors contributing to the development of thrombosis will be reviewed in this article. In addition we will focus on the prevention and management of arterial and venous thrombosis in patients with multiple myeloma.
Additional Metadata | |
---|---|
, , , , , , | |
doi.org/10.1016/S0049-3848(12)70024-5, hdl.handle.net/1765/73515 | |
Thrombosis Research: vascular obstruction, hemorrhage and hemostasis | |
Organisation | Department of Hematology |
Leebeek, F., Kruip, M., & Sonneveld, P. (2012). PL-17 risk and management of thrombosis in multiple myeloma. In Thrombosis Research: vascular obstruction, hemorrhage and hemostasis (Vol. 129). doi:10.1016/S0049-3848(12)70024-5 |